New

Explore professionally built ETF model portfolios. Discover now →

Advertisement
Advertisement

IXJvsPBPHETF Comparison

ETF 1
IXJ

iShares Global Healthcare ETF

This fund is part of
Global Large Cap
+0.01%
VS
ETF 2
PBPH

Portfolio Building Block World Pharma and Biotech Index ETF

This fund is part of
DM Large & Mid Cap
+0.01%

iShares Global Healthcare ETF (IXJ) belongs to the Global Large Cap segment. Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) is part of the DM Large & Mid Cap segment. IXJ's top 3 sector exposures are Health Care, Consumer Discretionary and Consumer Staples. In contrast, PBPH's top sector exposures are Health Care, Consumer Staples  IXJ is more expensive with a Total Expense Ratio (TER) of 0.4%, versus 0.13% for PBPH. IXJ is down -6.67% year-to-date (YTD) with -$729M in YTD flows. PBPH performs better with -2.73% YTD performance, and +$787M in YTD flows. Run a side-by-side ETF comparison of IXJ and PBPH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

IXJ vs PBPH performance and flow charts

Performance

-2.0-1.00.01.02.03.04.0%Mar 30Apr 7Apr 14Apr 21Apr 28

Cumulative Flows

-40 M-20 M0 M20 M40 MMar 30Apr 7Apr 14Apr 21Apr 28

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 04/29/2026
1M3MYTD1Y3Y5Y
Perf.
IXJ
PBPH
-1.05%-1.83%
-7.69%-5.37%
-6.67%-2.73%
+4.32%n/a
+9.37%n/a
+21.59%n/a
Flows
IXJ
PBPH
+$19M+$39M
-$888M+$757M
-$729M+$787M
-$450M-
-$1.07B-
+$205M-
Volatility and drawdown
3M1Y3Y5Y
Volatility
IXJ
PBPH
+15.16%+16.32%
+15.42%n/a
+13.25%n/a
+13.95%n/a
Max drawdown
IXJ
PBPH
-10.83%-9.94%
-10.83%n/a
-18.04%n/a
-18.04%n/a
Max drawdown duration
IXJ
PBPH
59d70d
59dn/a
490dn/a
490dn/a
Trading data

Create an account to view trading data

Join for free
IXJ
PBPH
Last sale
4/30/2026 at 1:30 PM
$92.93
$25.05
Previous close
04/29/2026
$90.75
$24.30
Consolidated volume
04/29/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of April 29, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
IXJ
PBPH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 4/30/2026 at 1:30 PM
Live
Closed
IXJ
PBPH
Last price
$92.93
$25.05
1D performance
+2.40%
+3.09%
AuM$3.53 B$725.81 M
E/R0.4%0.13%
Characteristics
IXJ
PBPH
Management strategyPassivePassive
ProvideriSharesTidal
BenchmarkS&P Global 1200 Health Care (Sector) Capped IndexBITA Global Pharma and Biotech Select Index
N° of holdings10449
Asset class--
Trailing 12m distribution yield
Join
Join
Inception dateNovember 13, 2001November 24, 2025
ESGNoNo
Advertisement
Exposure

Countries

IXJ
USA
68.5%
Switzerland
10.22%
Other
21.28%
PBPH
USA
63.05%
Switzerland
10.48%
Other
26.47%

Sectors

IXJ
Health Care
90.51%
Other
9.49%
PBPH
Health Care
85.65%
Other
14.35%
Advertisement

Diversification

IXJ

Total weight of top 15 holdings out of 15

56.56%
PBPH

Total weight of top 15 holdings out of 15

71.34%

Top 15 holdings

Data as of March 31, 2026
IXJ
LILLY
9.50%
JOHNSON&JOHNSON
7.68%
ABBVIE
5.01%
ASTRAZENECA
4.01%
MERCK & CO INC
3.98%
NOVARTIS
3.81%
CH1499059983
3.67%
UNITEDHEALTH GRP
3.27%
AMGEN-T
2.53%
THERMO FISHER SCIENTIFIC
2.46%
ABBOTT LABS
2.38%
GILEAD SCIENCES
2.31%
INTUITIVE SURGICAL
2.18%
PFIZER
2.13%
BRISTOL-MYERS SQUIBB
1.65%
PBPH
LILLY
12.31%
JOHNSON&JOHNSON
9.59%
ABBVIE
6.19%
MERCK & CO INC
4.79%
NOVARTIS
4.64%
CH1499059983
4.47%
GILEAD SCIENCES
4.42%
AMGEN-T
4.38%
PFIZER
4.13%
BRISTOL-MYERS SQUIBB
3.18%
DK0062498333
2.96%
VERTEX PHARMACEUTICALS
2.94%
SANOFI SA
2.68%
GSK PLC
2.67%
REGENERON PHARMACEUTICALS
2.00%
Frequently asked questions about IXJ and PBPH

How have the IXJ and PBPH ETFs performed in 2026?

As of April 29, 2026, IXJ is down -6.67% year-to-date (YTD), while PBPH has lost -2.73%. That puts PBPH better performer ahead so far this year.

Which ETF is attracting more investor money: IXJ or PBPH?

Year-to-date, the IXJ ETF saw -$729M in flows, compared to +$787M for PBPH.

Which ETF is bigger: IXJ or PBPH?

As of April 29, 2026, IXJ holds $3.53 B in assets under management (AUM), while PBPH manages $725.81 M.

What sectors do the IXJ and PBPH ETFs invest in?

IXJ leans toward sectors like Health Care. Meanwhile, PBPH focuses on Health Care.

What are the top holdings of the IXJ ETF and PBPH ETF?

IXJ top holdings include LILLY, JOHNSON&JOHNSON and ABBVIE. PBPH holds in its top three: LILLY, JOHNSON&JOHNSON and ABBVIE.

Which ETF is more diversified: IXJ or PBPH?

IXJ holds 114 securities with 56.56% of its assets in the top 15. PBPH has 52 securities and a top 15 weight of 71.34%.

Advertisement
Latest news about IXJ & PBPH
Advertisement
Advertisement
Advertisement
Webcast on Demand

Calamos Investments Powers the Next Phase of the Autocallable Revolution

Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.

Accepted for 1 CE Credit

Calamos Webcast